Conning’s Dova Pharmaceuticals DOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DOVA
Conning's DOVA Position: Q2 2018 in Review
Conning sold out of Dova Pharmaceuticals (DOVA) in Q2 2018, closing a stake of 50,000 shares — an estimated $1.36M sold.
Conning first reported a position in DOVA in Q2 2017 and held it in 4 quarters. The position peaked at $1.44M in Q4 2017. 60 funds tracked by Wall St. Rank hold DOVA as of Q2 2018.
- Conning reported no remaining Dova Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
- Conning sold 50,000 Dova Pharmaceuticals shares in Q2 2018, an estimated $1.36M.
- Conning first reported a position in Dova Pharmaceuticals in Q2 2017 and held it in 4 quarters.
- Conning's Dova Pharmaceuticals position peaked at $1.44M in Q4 2017.
- 60 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q2 2018.
Based on Conning's 13F filing for Q2 2018, filed 25 Jul 2018.